Have a personal or library account? Click to login
Oxidative Stress and Antioxidant Therapy in Critically Ill Polytrauma Patients with Severe Head Injury Cover

Oxidative Stress and Antioxidant Therapy in Critically Ill Polytrauma Patients with Severe Head Injury

The Journal of Critical Care Medicine
Volume 1 (2015): Issue 3 (July 2015)
By: Loredana Luca,  Alexandru Florin Rogobete and  Ovidiu Horea Bedreag  
Open Access
|Aug 2015

References

  1. 1. Bains M, Hall ED. Antioxidant therapies in traumatic brain and spinal cord injury. Biochim Biophys Acta - Mol Basis Dis. 2012;1822:675–84.10.1016/j.bbadis.2011.10.017413401022080976
    Search in Google Scholar
  2. 2. Humberto J, Mantilla M, Fernando L, Arboleda G. Revista Colombiana de Anestesiología Anesthesia for patients with traumatic brain injury. Colomb J Anesthesiol. 2015;43:3–8.
    Search in Google Scholar
  3. 3. Ashafaq M, Varshney L, Khan MHA, et al. Neuromodulatory effects of hesperidin in mitigating oxidative stress in streptozotocin induced diabetes. Biomed Res Int. 2014;2014: 249031.10.1155/2014/249031409050325050332
    Search in Google Scholar
  4. 4. Sies H. Redox Biology Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015;4:180–3.10.1016/j.redox.2015.01.002430986125588755
    Search in Google Scholar
  5. 5. Ribeiro A, Ferraz-de-Paula V, Pinheiro ML, et al. Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor. Eur J Pharmacol. 2012;678:78–85.10.1016/j.ejphar.2011.12.04322265864
    Search in Google Scholar
  6. 6. Abdul-Muneer PM, Chandra N, Haorah J. Interactions of Oxidative Stress and Neurovascular Inflammation in the Pathogenesis of Traumatic Brain Injury. Mol Neurobiol. 2015;51:966-7910.1007/s12035-014-8752-324865512
    Search in Google Scholar
  7. 7. Bibi H, Vinokur V, Waisman D, et al. Zn/Ga-DFO iron-chelating complex attenuates the inflammatory process in a mouse model of asthma. Redox Biol. 2014;2:814–9.10.1016/j.redox.2014.06.009408535125009783
    Search in Google Scholar
  8. 8. Hall ED, Vaishnav R a., Mustafa AG. Antioxidant Therapies for Traumatic Brain Injury. Neurotherapeutics. 2010;7:51–61.10.1016/j.nurt.2009.10.021281846520129497
    Search in Google Scholar
  9. 9. Miller DM, Singh IN, Wang JA, Hall ED. Nrf2 – ARE activator carnosic acid decreases mitochondrial dysfunction, oxidative damage and neuronal cytoskeletal degradation following traumatic brain injury in mice. Exp Neurol. 2015;264:103–10.10.1016/j.expneurol.2014.11.008432392425432068
    Search in Google Scholar
  10. 10. Rodríguez-Rodríguez A, Egea-Guerrero JJ, León-Justel A, et al. Role of S100B protein in urine and serum as an early predictor of mortality after severe traumatic brain injury in adults. Clin Chim Acta. 2012;414:228–33.10.1016/j.cca.2012.09.02523031665
    Search in Google Scholar
  11. 11. Strathmann FG, Schulte S, Goerl K, Petron DJ. Blood-based biomarkers for traumatic brain injury: evaluation of research approaches, available methods and potential utility from the clinician and clinical laboratory perspectives. Clin Biochem. 2014;47:876–88.10.1016/j.clinbiochem.2014.01.02824486649
    Search in Google Scholar
  12. 12. Kumar RG, Diamond ML, Boles JA, et al. Acute CSF interleukin-6 trajectories after TBI: Associations with neuroinflammation, polytrauma, and outcome. Brain Behav Immun. 2014;45:253–62.10.1016/j.bbi.2014.12.02125555531
    Search in Google Scholar
  13. 13. Falcone T, Janigro D, Lovell R, et al. S100B blood levels and childhood trauma in adolescent inpatients. J Psychiatr Res. 2014;62:14–22.10.1016/j.jpsychires.2014.12.002441393025669696
    Search in Google Scholar
  14. 14. Cervellin G, Benatti M, Carbucicchio A, et al. Serum levels of protein S100B predict intracranial lesions in mild head injury. Clin Biochem. 2012;45:408–11.10.1016/j.clinbiochem.2012.01.00622285378
    Search in Google Scholar
  15. 15. Dal-Pizzol F, Ritter C, Cassol-Jr OJ, et al. Oxidative mechanisms of brain dysfunction during sepsis. Neurochem Res. 2010;35:1–12.10.1007/s11064-009-0043-419680806
    Search in Google Scholar
  16. 16. Hol EM, Pekny M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol. 2015;32C:121–30.10.1016/j.ceb.2015.02.00425726916
    Search in Google Scholar
  17. 17. Feneberg E, Steinacker P, Lehnert S, Böhm B, Mayer G, Otto M. Elevated glial fibrillary acidic protein levels in the cerebrospinal fluid of patients with narcolepsy. Sleep Med. 2013;14:692–4.10.1016/j.sleep.2013.04.01323746601
    Search in Google Scholar
  18. 18. Tennakoon AH, Izawa T, Wijesundera KK, et al. Immunohistochemical characterization of glial fibrillary acidic protein (GFAP)-expressing cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA). Exp Toxicol Pathol. 2015;67:53–63.10.1016/j.etp.2014.09.00825446803
    Search in Google Scholar
  19. 19. Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie L. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients’ mortality: A prospective observational study. PLoS One. 2012;7:1–9.10.1371/journal.pone.0038885337614522719975
    Search in Google Scholar
  20. 20. Abdul-Muneer PM, Schuetz H, Wang F, et al. Induction of oxidative and nitrosative damage leads to cerebrovascular inflammation in an animal model of mild traumatic brain injury induced by primary blast. Free Radic Biol Med. 2013;60:282–91.10.1016/j.freeradbiomed.2013.02.029400717123466554
    Search in Google Scholar
  21. 21. Petzold A. Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease. Brain Res. 2014;1600:17–31.10.1016/j.brainres.2014.12.02725543069
    Search in Google Scholar
  22. 22. Kärkelä J, Bock E, Kaukinen S. CSF and serum brain-specific creatine kinase isoenzyme (CK-BB), neuron-specific enolase (NSE) and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man. J Neurol Sci. 1993;116:100–9.10.1016/0022-510X(93)90095-G
    Search in Google Scholar
  23. 23. Prasad KN, Bondy SC. Common biochemical defects linkage between post-traumatic stress disorders, mild traumatic brain injury (TBI) and penetrating TBI. Brain Res. 2015;1599:103–14.10.1016/j.brainres.2014.12.03825553619
    Search in Google Scholar
  24. 24. El-Maraghi S, Yehia H, Hossam H, Yehia A, Mowafy H. The prognostic value of neuron specific enolase in head injury. Egypt J Crit Care Med. 2013;1:25–32.10.1016/j.ejccm.2012.12.002
    Search in Google Scholar
  25. 25. Klevay LM. Myelin and traumatic brain injury: the copper deficiency hypothesis. Med Hypotheses. 2013;81:995–8.10.1016/j.mehy.2013.09.01124120700
    Search in Google Scholar
  26. 26. Barco S, Gennai I, Reggiardo G, et al. Urinary homovanillic and vanillylmandelic acid in the diagnosis of neuroblastoma: report from the Italian Cooperative Group for Neuroblastoma. Clin Biochem. 2014;47:848–52.10.1016/j.clinbiochem.2014.04.01524769278
    Search in Google Scholar
  27. 27. Dash PK, Zhao J, Hergenroeder G, Moore AN. Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury. Neurotherapeutics. 2010;7:100–14.10.1016/j.nurt.2009.10.019508411720129502
    Search in Google Scholar
  28. 28. LeWitt P, Schultz L, Auinger P, Lu M. CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson’s disease. Brain Res. 2011;1408:88–97.10.1016/j.brainres.2011.06.057412002021784416
    Search in Google Scholar
  29. 29. Homsi S, Federico F, Croci N, et al. Minocycline effects on cerebral edema: Relations with inflammatory and oxidative stress markers following traumatic brain injury in mice. Brain Res. 2009;1291:122–32.10.1016/j.brainres.2009.07.03119631631
    Search in Google Scholar
  30. 30. Zampieri FG, Kellum J A, Park M, et al. Relationship between acid-base status and inflammation in the critically ill. Crit Care. 2014;18:R154.10.1186/cc13993422354525034180
    Search in Google Scholar
  31. 31. Ansari M a., Roberts KN, Scheff SW. Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury. Free Radic Biol Med. 2008;45:443–52.10.1016/j.freeradbiomed.2008.04.038258682718501200
    Search in Google Scholar
  32. 32. Wannhoff A, Bölck B, Kübler AC, Bloch W, Reuther T. Oxidative and nitrosative stress and apoptosis in oral mucosa cells after ex vivo exposure to lead and benzo[a]pyrene. Toxicol In Vitro. 2013;27:915–21.10.1016/j.tiv.2013.01.00723318731
    Search in Google Scholar
  33. 33. Hohl A, Gullo JDS, Silva CCP, et al. Plasma levels of oxidative stress biomarkers and hospital mortality in severe head injury: A multivariate analysis. J Crit Care. 2012;27:523.e11–523.e19.10.1016/j.jcrc.2011.06.00721803537
    Search in Google Scholar
  34. 34. Ji H-H, Huang G-L, Yin H-X, Xu P, Luo S-Y, Song J-K. Association between microRNA-196a2 rs11614913, microRNA-146a rs2910164, and microRNA-423 rs6505162 polymorphisms and esophageal cancer risk: A meta-analysis. Meta Gene. 2015;3:14–25.10.1016/j.mgene.2014.12.001472248626925372
    Search in Google Scholar
  35. 35. Muraoka T, Soh J, Toyooka S, et al. The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma. Lung Cancer. 2013;82:485–90.10.1016/j.lungcan.2013.09.01724168922
    Search in Google Scholar
  36. 36. Li Y, Dalli J, Chiang N, Baron RM, Quintana C, Serhan CN. Plasticity of leukocytic exudates in resolving acute inflammation is regulated by MicroRNA and proresolving mediators. Immunity. 2013;39:885–98.10.1016/j.immuni.2013.10.011388851724238341
    Search in Google Scholar
  37. 37. Li G, Luna C, Qiu J, Epstein DL, Gonzalez P. Alterations in microRNA expression in stress-induced cellular senescence. Mech Ageing Dev. 2009;130:731–41.10.1016/j.mad.2009.09.002279506419782699
    Search in Google Scholar
  38. 38. Suh JH, Choi E, Cha M-J, et al. Up-regulation of miR-26a promotes apoptosis of hypoxic rat neonatal cardiomyocytes by repressing GSK-3β protein expression. Biochem Biophys Res Commun. 2012;423:404–10.10.1016/j.bbrc.2012.05.13822664106
    Search in Google Scholar
  39. 39. Miller A-F. Superoxide dismutases: ancient enzymes and new insights. FEBS Lett. 2012;586:585–95.10.1016/j.febslet.2011.10.048544368122079668
    Search in Google Scholar
  40. 40. Gerbaud P, Petzold L, Thérond P, Anderson WB, Evain-Brion D, Raynaud F. Differential regulation of Cu, Zn- and Mn-superoxide dismutases by retinoic acid in normal and psoriatic human fibroblasts. J Autoimmun. 2005;24:69–78.10.1016/j.jaut.2004.10.00315725579
    Search in Google Scholar
  41. 41. Pilon M, Ravet K, Tapken W. The biogenesis and physiological function of chloroplast superoxide dismutases. Biochim Biophys Acta. 2011;1807:989–98.10.1016/j.bbabio.2010.11.00221078292
    Search in Google Scholar
  42. 42. Comar JF, Babeto De Sá-Nakanishi A, De Oliveira AL, et al. Oxidative state of the liver of rats with adjuvant-induced arthritis. Free Radic Biol Med. 2013;58:144–53.10.1016/j.freeradbiomed.2012.12.00323246655
    Search in Google Scholar
  43. 43. Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J. 2006;28:219–42.10.1183/09031936.06.0005380516816350
    Search in Google Scholar
  44. 44. Lazzarino G, Di Pietro V, Lazzarino G, et al. Neuroglobin expression and oxidant/antioxidant balance after graded traumatic brain injury in the rat. Free Radic Biol Med. 2014;69:258–64.10.1016/j.freeradbiomed.2014.01.03224491879
    Search in Google Scholar
  45. 45. Hybertson BM, Gao B, Bose SK, McCord JM. Oxidative stress in health and disease: The therapeutic potential of Nrf2 activation. Mol Aspects Med. 2011;32:234–46.10.1016/j.mam.2011.10.00622020111
    Search in Google Scholar
  46. 46. Elkharaz J, Ugun-Klusek A, Constantin-Teodosiu D, et al. Implications for oxidative stress and astrocytes following 26S proteasomal depletion in mouse forebrain neurones. Biochim Biophys Acta - Mol Basis Dis. 2013;1832:1959–68.10.1016/j.bbadis.2013.07.00223851049
    Search in Google Scholar
  47. 47. Li L, Zhu K, Liu Y, et al. Targeting Thioredoxin-1 With Sirna Exacerbates Oxidative Stress Injury After Cerebral Ischemia / Reperfusion in Rats. 2015;284:815–23.
    Search in Google Scholar
  48. 48. Andrés NC, Fermento ME, Gandini NA, et al. Heme oxygenase-1 has antitumoral effects in colorectal cancer: involvement of p53. Exp Mol Pathol. 2014;97:321–31.10.1016/j.yexmp.2014.09.01225236576
    Search in Google Scholar
  49. 49. Yu JH, Cho SO, Lim JW, Kim N, Kim H. Ataxia telangiectasia mutated inhibits oxidative stress-induced apoptosis by regulating heme oxygenase-1 expression. Int J Biochem Cell Biol. 2015;60:147–56.10.1016/j.biocel.2015.01.00225592228
    Search in Google Scholar
  50. 50. Namba F, Go H, Murphy J A., et al. Expression level and subcellular localization of heme oxygenase-1 modulates its cytoprotective properties in response to lung injury: A mouse model. PLoS One. 2014;9:1–11.10.1371/journal.pone.0090936394497924599172
    Search in Google Scholar
  51. 51. Kurtz P, Claassen J, Helbok R, et al. Systemic glucose variability predicts cerebral metabolic distress and mortality after subarachnoid hemorrhage: a retrospective observational study. Crit Care. 2014;18:R89.10.1186/cc13857405669324887049
    Search in Google Scholar
  52. 52. Beschorner R, Adjodah D, Schwab JM, et al. Long-term expression of heme oxygenase-1 (HO-1, HSP-32) following focal cerebral infarctions and traumatic brain injury in humans. Acta Neuropathol. 2000;100:377–84.10.1007/s00401000020210985695
    Search in Google Scholar
  53. 53. Bhalla P, Dhawan DK. Protective Role of Lithium in Ameliorating the Aluminium-induced Oxidative Stress and Histological Changes in Rat Brain. Cell Mol Neurobiol. 2009;29:513–21.10.1007/s10571-008-9343-5
    Search in Google Scholar
  54. 54. Blass SC, Goost H, Tolba RH, et al. Time to wound closure in trauma patients with disorders in wound healing is shortened by supplements containing antioxidant micronutrients and glutamine: A PRCT. Clin Nutr. 2012;31:469–75.10.1016/j.clnu.2012.01.002
    Search in Google Scholar
  55. 55. Şener G, Toklu H, Kapucu C, et al. Melatonin protects against oxidative organ injury in a rat model of sepsis. Surg Today. 2005;35:52–9.10.1007/s00595-004-2879-1
    Search in Google Scholar
  56. 56. Dehghan F, Khaksari Hadad M, Asadikram G, Najafipour H, Shahrokhi N. Effect of melatonin on intracranial pressure and brain edema following traumatic brain injury: Role of oxidative stresses. Arch Med Res. 2013;44:251–8.10.1016/j.arcmed.2013.04.002
    Search in Google Scholar
  57. 57. Yürüker V, Naz M, Nilgün Ş. Reduction in traumatic brain injury-induced oxidative stress, apoptosis, and calcium entry in rat hippocampus by melatonin: Possible involvement of TRPM2 channels. Metab Brain Dis. 2015;30:223–31.10.1007/s11011-014-9623-3
    Search in Google Scholar
  58. 58. Bhalla a., Singhal M, Suri V, Malhotra S, Shafiq N, Varma S. Methylprednisolone in dengue patients with alarm signs: The MIDWAS study. Int J Infect Dis. 2014;21:323.10.1016/j.ijid.2014.03.1087
    Search in Google Scholar
  59. 59. Grasbon-Frodl EM, Nakao N, Brundin P. The lazaroid U-83836E improves the survival of rat embryonic mesencephalic tissue stored at 4°C and subsequently used for cultures or intracerebral transplantation. Brain Res Bull. 1996;39:341–7.10.1016/0361-9230(96)00001-9
    Search in Google Scholar
  60. 60. Porfire AS, Leucuţa SE, Kiss B, Loghin F, Pârvu AE. Investigation into the role of Cu/Zn-SOD delivery system on its antioxidant and antiinflammatory activity in rat model of peritonitis. Pharmacol Reports. 2014;66:670–6.10.1016/j.pharep.2014.03.01124948070
    Search in Google Scholar
  61. 61. Schmatz R, Perreira LB, Stefanello N, et al. Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochimie. 2012;94:374–83.10.1016/j.biochi.2011.08.00521864646
    Search in Google Scholar
  62. 62. Koz ST, Etem EO, Baydas G, et al. Effects of resveratrol on blood homocysteine level, on homocysteine induced oxidative stress, apoptosis and cognitive dysfunctions in rats. Brain Res. 2012;1484:29–38.10.1016/j.brainres.2012.09.02622995369
    Search in Google Scholar
  63. 63. Song L, Chen L, Zhang X, Li J, Le W. Resveratrol Ameliorates Motor Neuron Degeneration and Improves Survival in SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis. Biomed Res Int. 2014;2014:483501.10.1155/2014/483501409571125057490
    Search in Google Scholar
  64. 64. Gao J, Koshio S, Ishikawa M, Yokoyama S, Mamauag REP. Interactive effects of vitamin C and E supplementation on growth performance, fatty acid composition and reduction of oxidative stress in juvenile Japanese flounder Paralichthys olivaceus fed dietary oxidized fish oil. Aquaculture. 2014;422-423:84–90.10.1016/j.aquaculture.2013.11.031
    Search in Google Scholar
  65. 65. Fox ED, Heffernan DS, Cioffi WG, Reichner JS. Neutrophils from critically ill septic patients mediate profound loss of endothelial barrier integrity. Crit Care. 2013;17:R226.10.1186/cc13049405723024099563
    Search in Google Scholar
  66. 66. Chen Q, Jones D, Stone P, Ching LM, Chamley L. Vitamin C Enhances Phagocytosis of Necrotic Trophoblasts by Endothelial Cells and Protects the Phagocytosing Endothelial Cells from Activation. Placenta. 2009;30:163–8.10.1016/j.placenta.2008.11.00719070894
    Search in Google Scholar
  67. 67. Oudemans-van Straaten HM, Man A, de Waard MC. Vitamin C revisited. Crit Care. 2014;18:460.10.1186/s13054-014-0460-x442364625185110
    Search in Google Scholar
  68. 68. Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg. 2002;236:814–22.10.1097/00000658-200212000-00014142264812454520
    Search in Google Scholar
  69. 69. Nagaraja D, Noone ML, Bharatkumar VP, Christopher R. Homocysteine, folate and vitamin B12 in puerperal cerebral venous thrombosis. J Neurol Sci. 2008;272:43–7.10.1016/j.jns.2008.03.02118617193
    Search in Google Scholar
  70. 70. Şenol N, NazIroǧlu M, Yürüker V. N-acetylcysteine and selenium modulate oxidative stress, antioxidant vitamin and cytokine values in traumatic brain injury-induced rats. Neurochem Res. 2014;39:685–92.10.1007/s11064-014-1255-924519543
    Search in Google Scholar
  71. 71. Navarro-Yepes J, Zavala-Flores L, Anandhan A, et al. Antioxidant gene therapy against neuronal cell death. Pharmacol Ther. 2014;142:206–30.10.1016/j.pharmthera.2013.12.007395958324333264
    Search in Google Scholar
DOI: https://doi.org/10.1515/jccm-2015-0014 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Journal RSS Feed
Language: English
Page range: 83 - 91
Submitted on: Apr 8, 2015
|
Accepted on: Jul 16, 2015
|
Published on: Aug 6, 2015
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
antioxidant therapy,
oxidative stress,
traumatic brain injury,
multiple trauma patients
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Surgery,
Surgery, other,
Anaesthesiology,
Emergency medicine and intensive-care medicine

© 2015 Loredana Luca, Alexandru Florin Rogobete, Ovidiu Horea Bedreag, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 1 (2015): Issue 3 (July 2015)Next article